 | |
- close
- close
|
StreetInsider.com
11 hrs ago
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Warner+Chilcott+%28WCRX%29+Misses+Q3+Views+by+1c/5086773.html for the full story.
PR Newswire
11 hrs ago
Comment
ARDEE, Ireland, Nov. 9 /PRNewswire-FirstCall/ -- Warner Chilcott plc (Nasdaq: WCRX) today announced its results for the quarter ended September 30, 2009. Revenue in the quarter ended September 30, 2009 increased 9.0% to $252.8 million over the prior
PR Newswire
Nov 4
Comment
SEOUL, Korea, Nov. 4 /PRNewswire/ -- Dong-A PharmTech Co. Ltd., announced that its U.S. partner, Warner Chilcott plc, has initiated two, phase III trials for udenafil, a new long acting drug under development for erectile dysfunction (ED). Each
PR Newswire
Nov 2
Comment
ARDEE, Ireland, Nov. 2 /PRNewswire-FirstCall/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today that it will issue its third quarter 2009 financial results prior to the market opening on Monday, November 9, 2009. In addition to issuing a press
PR Newswire
Oct 30
Comment
ARDEE, Ireland, Oct. 30 /PRNewswire-FirstCall/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today it has completed the acquisition of The Procter & Gamble Company's global branded prescription pharmaceutical business. The acquisition complements
PR Newswire
Oct 20
Comment
ARDEE, Ireland, Oct. 20 /PRNewswire-FirstCall/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today that Dr. Mahdi Fawzi has joined the company as President, Global Research and Development. He joins Warner Chilcott from Wyeth Pharmaceuticals, where
Business Standard
Oct 10
Comment
Teva Women's Health of Israel and Warner Chilcott of Puerto Rico have sued Indias Lupin in separate patent infringement cases in the US. This is being seen as an attempt to block the Indian companys plans to tap the $3.3 billion (Rs 13,860 crore)...
Reuters
Sep 30
Comment
U.S. antitrust regulators have approved Warner Chilcott Plc's purchase of Procter & Gamble Co's pharmaceuticals business, the Federal Trade Commission said on Wednesday.
Reuters
Sep 25
Comment
* Issuance of syndicated loans still slowest since 2000
(For a collection of stories and FACTBOXES on M&A activity so
far this year click on [ID:nN24461018])
FierceBiotech
Sep 23
Comment
Leo Pharma will reacquire the licensing rights to its topical psoriasis treatments from Warner Chilcott for about $1 billion, the two drugmakers announced today. The deal, which is expected to be completed today, will result in a one-time gain...
|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
WCRX AT A GLANCE
References
| ||||||
|
|
